COMPASS Pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first major initiative is developing psilocybin therapy through late-stage clinical trials in the EU and US for patients with treatment-resistant depression. We are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

Legal name: Compass Pathways PLC